'JIAO PENGYOU'-A Guide for Successful Business Relationships in China
March 1, 2011
Foley Partner James Chapman authored an article that appeared in the March 2011 issue of the American Management Association’s Leader’s Edge newsletter titled “’JIAO PENGYOU’—A Guide for Successful Business Relationships in China.” Chapman provides an overview of best practices for U.S. companies entering the business environment in China, including the use of strong contractual protections and early trademark and patent registration. He adds that building and maintaining successful business relationships in China is a challenge, but notes that companies can succeed by following a number of best practices for a rapidly changing business environment.
Click here to read the complete article.
Related Insights
June 26, 2026
Health Care Law Today
California Attorney General Escalates Attack on PC-MSO Model: What Venture-Backed, Private Equity, and Digital Health Companies Need to Know
Foley & Lardner LLP (Foley) represented Carbon Health in negotiating a settlement agreement with the California Attorney General (AG) to resolve alleged corporate practice of medicine (CPOM) violations against Carbon Health, a technology-based primary and urgent care company that recently emerged from Chapter 11 bankruptcy.
June 26, 2026
Foley Viewpoints
17 States Challenge California Packaging Law With National Supply Chain Stakes
On June 22, 2026, 17 states, led by Nebraska, along with the National Association of Wholesaler-Distributors (NAW), sued California regulators and the Circular Action Alliance (CAA) in federal court, seeking to invalidate the state’s landmark packaging law, SB 54 (“SB 54” or “the Act”). The lawsuit, Nebraska v. Heller, is the first coordinated, multistate attack on the broader “extended producer responsibility” (EPR) model gaining traction for packaging regulation across the United States.
June 25, 2026
Foley Viewpoints
DOJ’s 2026 Health Care Fraud Takedown: Details Behind the Headline Number and What It Means for Health Care Providers
For health care companies, investors, management services organizations, provider platforms, and boards, the more important message is more specific: the government is now treating fast-growing reimbursement categories as data-driven, enterprise-risk environments.